Praxis Precision Medicines, Inc. (PRAX) Net Income by Year
Praxis Precision Medicines, Inc. reported a net loss of $303.0M in fiscal year 2025. This represents a decrease of 65.6% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Praxis Precision Medicines, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PRAX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
PRAX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Praxis Precision Medicines, Inc. financials
Frequently Asked Questions
What was Praxis Precision Medicines, Inc.'s net income in fiscal year 2025?
Praxis Precision Medicines, Inc. reported a net loss of $303.0M in fiscal year 2025.
How fast is Praxis Precision Medicines, Inc.'s net income growing?
Praxis Precision Medicines, Inc. (PRAX) net income fell by 65.6% year over year, from -$183.0M to -$303.0M in fiscal year 2025.
How has Praxis Precision Medicines, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Praxis Precision Medicines, Inc. (PRAX) net income went from -$35.5M in fiscal year 2019 to -$303.0M in fiscal year 2025.
What was Praxis Precision Medicines, Inc.'s net income in the most recent quarter?
Praxis Precision Medicines, Inc. (PRAX) reported -$83.7M in net income in Q2 2026. This represents a decrease of 17.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Praxis Precision Medicines, Inc. (PRAX) reported on that line in every period on record.